S.G. Power Limited (PSX: SGPL) has approved a 300 percent right share issue aimed at raising over Rs. 534 million to finance expansion into the healthcare and pharmaceutical sectors.
According to the company’s notification submitted to the Pakistan Stock Exchange, the board approved the issuance of 53.49 million ordinary right shares at par value of Rs. 10 per share during its meeting held on May 18, 2026.
The proposed right issue represents approximately three right shares for every one ordinary share currently held by shareholders.
The company said the transaction remains subject to shareholder approval and regulatory clearances from the Securities and Exchange Commission of Pakistan.
S.G. Power stated that the primary objective of the capital raise is to support investments in healthcare and related businesses as part of its long-term diversification and growth strategy.
The company said the proceeds will be used to strengthen its financial position, expand operations, improve its equity base, and pursue strategic opportunities within the healthcare industry.
According to the filing, substantial shareholders and directors have committed to subscribing to their respective entitlements, while the remaining portion of the issue will be fully underwritten in line with regulatory requirements.
The company added that the right issue is expected to improve financial flexibility and help generate more sustainable returns for shareholders through diversification into healthcare-related businesses.